Hepatoblastoma, Radiology
Conditions
Brief summary
Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma with chest CT as gold standard
Interventions
None listed
Sponsors
RenJi Hospital
Study design
Observational model
CASE_ONLY
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 14 Years
Inclusion criteria
* Children diagnosed as hepatoblastoma (including treated with neoadjuvant chemotherapy but not surgery) * Recent chest CT scan (within 14 days) * No MRI contraindications * The guardian of the children are willing to undergo the examination after full communication and informed consent
Exclusion criteria
* MRI contraindications (including but not limited to: contrast medium allergy; Claustrophobia;Metal implants;chronic kidney disease≥stage 3 (glomerular filtration rate \< 60 mL min-1 (1.73 m2)-1)) * Patients with hepatoblastoma aged 14 years and above * Children after surgery for hepatoblastoma * Application of any contrast medium within 24 h before the MRI and/or CT examinations * There is a concomitant medical condition (e.g. poorly controlled hypertension, severe diabetes, neurological or psychiatric illness, etc.) or any other condition that would seriously endangers the subject's safety, may confuse the study results, or may interfere with the subject's completion of the study according to the investigator's judgment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| UTE-MRI assessment of lung metastases with chest CT as gold standard | Baseline to 14 days | Analyze the diagnostic efficiency (including performance, diameter, and location of nodules) of UTE-MRI in lung metastases of hepatoblastoma. |
Countries
China
Outcome results
None listed